TruStem Cell Therapy™ for Stroke Recovery
Difficult understanding speech
Difficulty speaking
Confusion
Memory deficits
Inability to move on one side of the body
Loss of sensation on one side of the body
A spinning sensation
Loss of vision
Reduced muscle tone
Difficulty with balance
Facial weakness
Severe headache
What is a Stroke?
A stroke occurs when the blood supply to the brain is interrupted. This can occur as the result of the blockage of blood flow, such as by a clot (ischemic stroke). It may also occur from bleeding into the brain, call a hematoma, which compresses nearby tissue, blocks blood flow, causing damage. Due to the resulting tissue injury a number of transient and long-term symptoms and complications are produced by the occurrence of a stroke, potentially reducing an individual’s quality of life severely.
There are three main types of stroke:
Ischemic Stroke
– caused by blood clots
Hemorrhagic stroke
– caused by ruptured blood vessels that cause brain bleeding
Transient ischemic attack (TIA)
– caused by a temporary blood clot, also known as a “mini stroke”
What causes Stroke?
Ischemic strokes can be caused by blood clots, which can form either in the arteries connecting to the brain, or in other blood vessels before being swept through the bloodstream and into narrower arteries of the brain.
Hemorrhagic strokes can be caused by conditions such as hypertension, trauma, blood-thinning medications and aneurysms.
TIAs are similar to Hemorrhagic strokes as they are also caused by blood clots or other debris.
What type of stem cells are used and why?
TruStem Cell Therapy provides access to treatment that utilizes a patient’s stem cells isolated from their own bone marrow. There are multiple inherent benefits afforded by the utilization of bone marrow derived stem cells as Bone marrow (BM) and bone marrow components function in various diverse, innate therapeutic capacities.
Hematopoietic stem cells (HSCs), found within BM, are the body’s source of most cells found in the peripheral or circulating blood. These include red blood cells and white blood cells (such as monocytes). Evidence suggests that BM-derived monocytes may act to improve certain neurodegenerative conditions. In this disease environment exhausted microglia cannot efficiently clear A𝛽 deposits, leading to peptide buildup and neurodegeneration. In this state, monocytes easily bypass the compromised blood-brain-barrier, adhere to A𝛽 positive veins, then phagocytose and transport peptide from the brain microvasculature into the circulating blood.
In addition to HSCs, mesenchymal stem cells (MSCs) are also contained within BM. Evidence suggests MSCs can enter the circulating blood during injury and have been shown to readily home to areas of injury or inflammation. Once at these damaged tissue sites, MSCs can exert both protective cellular and immunomodulatory effects believed to be critical in many neurological and autoimmune conditions.
What steps are involved in receiving treatment through TruStem Cell Therapy?
Harvest
First a blood draw is performed followed by a minimally invasive bone marrow harvest via the iliac crest. Approximately 100cc’s of a patient’s own bone marrow is harvested through a minimally invasive, bone marrow aspiration procedure. TruStem Cell Therapy utilizes a powered bone marrow access system combined with local anesthetic allowing for consistently larger specimen of cells, extremely low levels of pain/invasiveness reported by most patients, and higher levels of sterility.
Bone marrow aspirate is preferentially utilized because it is one of the richest, most accessible sources of stem cells in the human body and falls within the FDA guidelines of minimal manipulation.
Process + Activate
Both the blood and bone marrow are immediately delivered to our dedicated, onsite laboratory staffed by our team of technicians. Once your sample is in the lab our advanced proprietary process isolates and excites regenerative cells and concentrates healing factors to hyper-physiological levels in order to facilitate the creation of a highly effective, injectable therapeutic.
Stem cell activation is part of what makes TruStem Cell Therapy unique. The activation procedure is designed to augment efficacy.
Administer
TruStem Cell Therapy utilizes both systematic and novel administration methods to fully saturate the body with stem cells while targeting specific areas of injury.
How are stem cells administered back into stroke patients through TruStem Cell Therapy?
Stroke patients who receive stem cell therapy through us can receive both systemic and targeted administration methods:
-
Systemic IV infusion of their stem cells to fully saturate the entire body.
-
Intranasal administration to target areas of damage and necrosis in the central nervous system
-
Localized injections into atrophied or spastic muscles
What is unique about receiving stem cell therapy through TruStem Cell Therapy for Stroke?
Our focus is safety, efficacy, and patient-centric care when providing access to superior stem cell therapy.
We utilize only board certified surgeons, physicians and accredited clinicians to provide care for patients.
Laboratory protocols are developed and refined by our PhD Neuroscientist.
A clinical team with expertise in practicing cellular based medicine.
Accredited Surgical Centers for enhanced procedural and patient safety
Targeted administration methods that direct stem cells toward specific
Skilled Patient Advocates who are trained to provide truthful, realistic expectations resulting from stem cell therapy. We do not make outlandish promises of cures or inaccurate claims related to improvement rates.
Can this treatment cure Stroke?
It is important for patients and caregivers to understand that current therapies, including stem cell treatment, does not provide a cure for Stroke. However, TruStem cell therapy does have the potential to improve a patient’s quality of life by reducing symptoms and complications related to Stroke as well as slowing its progression.
